HighMark Wealth Management LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 409 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
HighMark Wealth Management LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,571
-99.9%
30
-99.9%
0.00%
-99.9%
Q4 2023$1,156,478
-3.2%
31,2900.0%0.85%
-14.0%
Q3 2023$1,195,278
-20.7%
31,290
-25.1%
0.99%
-12.5%
Q2 2023$1,507,365
-5.6%
41,7900.0%1.13%
-9.0%
Q1 2023$1,595,960
-32.9%
41,7900.0%1.24%
-30.6%
Q4 2022$2,377,851
+24.0%
41,790
-13.8%
1.79%
+9.5%
Q3 2022$1,917,000
-13.2%
48,490
-3.4%
1.64%
-7.8%
Q2 2022$2,208,000
+11.4%
50,190
+1.0%
1.78%
+33.9%
Q1 2022$1,982,000
-6.3%
49,690
-5.5%
1.33%
-1.1%
Q4 2021$2,115,000
-2.5%
52,590
-1.4%
1.34%
-16.0%
Q3 2021$2,170,000
-10.6%
53,341
-0.2%
1.60%
-10.5%
Q2 2021$2,427,000
+156.3%
53,457
+25.2%
1.78%
+136.3%
Q1 2021$947,000
+0.1%
42,712
+92.9%
0.76%
-7.1%
Q4 2020$946,000
+30.8%
22,146
-19.5%
0.81%
+24.9%
Q3 2020$723,000
+4152.9%
27,515
+4159.3%
0.65%
+3326.3%
Q2 2020$17,0006460.02%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders